Furthermore, it can inhibit ovarian cancer cell proliferation by inducing apoptosis, autophagy, cellular stress, and cell cycle G1 arrest through the inhibition of AKT/mTOR and activation of the mitogen-activated protein kinase (MAPK) pathways (Jones et al., 2017). The gene discussed is AKT1; the disease is ovarian carcinoma.